Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Nov 21, 2022 · 10-Q · 52 days after period end · 0001477932-22-008809
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$4.82M | -$4.45M | -$327.07K | -$19.17K |
| EPS Diluted | -$0.01 | -$0.02 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 21, 2022 · 52 d after period end
